These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8220297)

  • 1. Vitamin E in extrapyramidal disorders.
    Bischot L; Van den Brink G; Porsius AJ
    Pharm World Sci; 1993 Aug; 15(4):146-50. PubMed ID: 8220297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
    Pham DQ; Plakogiannis R
    Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tardive dyskinesia with vitamin E.
    Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
    Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
    Adler LA; Rotrosen J; Edson R; Lavori P; Lohr J; Hitzemann R; Raisch D; Caligiuri M; Tracy K
    Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
    Sajjad SH
    Int Clin Psychopharmacol; 1998 Jul; 13(4):147-55. PubMed ID: 9727725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
    Dorevitch A; Lerner V; Shalfman M; Kalian M
    Int Clin Psychopharmacol; 1997 May; 12(3):171-3. PubMed ID: 9248874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol-induced extrapyramidal reaction: lack of protective effect by vitamin E.
    Eranti VS; Gangadhar BN; Janakiramaiah N
    Psychopharmacology (Berl); 1998 Dec; 140(4):418-20. PubMed ID: 9888616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
    Dabiri LM; Pasta D; Darby JK; Mosbacher D
    Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
    Lerner V; Miodownik C; Kaptsan A; Bersudsky Y; Libov I; Sela BA; Witztum E
    J Clin Psychiatry; 2007 Nov; 68(11):1648-54. PubMed ID: 18052557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C.
    Michael N; Sourgens H; Arolt V; Erfurth A
    Neuropsychobiology; 2002; 46 Suppl 1():28-30. PubMed ID: 12571430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.
    Adler LA; Peselow E; Duncan E; Rosenthal M; Angrist B
    Psychopharmacol Bull; 1993; 29(3):371-4. PubMed ID: 8121964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial.
    Emsley R; Niehaus DJ; Koen L; Oosthuizen PP; Turner HJ; Carey P; van Rensburg SJ; Maritz JS; Murck H
    Schizophr Res; 2006 May; 84(1):112-20. PubMed ID: 16632329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged.
    Vatassery GT; Bauer T; Dysken M
    Am J Clin Nutr; 1999 Nov; 70(5):793-801. PubMed ID: 10539737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.